The 88 references without contexts in paper A. Smirnov V., V. Dobronravov A., A. Rumyantsev Sh., E. Shilov M., A. Vatazin ., I. Kayukov G., A. Kucher G., M. Yesayan A., А. Смирнов В., В. Добронравов А., А. Румянцев Ш., Е. Шилов М., А. Ватазин В., И. Каюков Г., А. Кучер Г., А. Есаян М. (2016) “НАЦИОНАЛЬНЫЕ РЕКОМЕНДАЦИИ. ОСТРОЕ ПОВРЕЖДЕНИЕ ПОЧЕК: ОСНОВНЫЕ ПРИНЦИПЫ ДИАГНОСТИКИ, ПРОФИЛАКТИКИ И ТЕРАПИИ. ЧАСТЬ I // NATIONAL GUIDELINES ACUTE KIDNEY INJURY: BASIC PRINCIPLES OF DIAGNOSIS, PREVENTION AND THERAPY. PART I” / spz:neicon:nefr:y:2016:i:1:p:79-104

1
Добронравов ВА. Обзор патофизиологии острого повреждения почек. В: Смирнов АВ, Добронравов ВА, Румянцев АШ, Каюков ИГ. Острое повреждение почек. МИА, М., 2015; 30-79
(check this in PDF content)
2
Каюков ИГ, Смирнов АВ, Эмануэль ВЛ. Цистатин С в современной медицине. Нефрология 2012; 16(1): 22–39
(check this in PDF content)
3
Каюков ИГ, Смирнов АВ. Рентгеноконтрастная нефропатия. В: Мухин НА, ред. Нефрология. Национальное руководство.
(check this in PDF content)
4
ГЭОТАР-Медиа, М., 2009; 688-704
(check this in PDF content)
5
Смирнов АВ. Клиника и диагностика острого повреждения почек. В: Смирнов АВ, Добронравов ВА, Румянцев АШ, Каюков ИГ. Острое повреждение почек. МИА, М., 2015; 80-206
(check this in PDF content)
6
Смирнов АВ. Клинические синдромы острого повреждения почек. В: Смирнов АВ, Добронравов ВА, Румянцев АШ, Каюков ИГ. Острое повреждение почек. МИА, М., 2015; 207-304
(check this in PDF content)
7
Смирнов АВ, Добронравов ВА, Каюков ИГ. Кардиоренальный континуум: патогенетические основы превентивной нефрологии. Нефрология 2005; 9(3): 7-15
(check this in PDF content)
8
Смирнов АВ, Каюков ИГ, Дегтерева ОА и др. Проблемы диагностики и стратификации тяжести острого повреждения почек. Нефрология 2009; 13(3): 9-18
(check this in PDF content)
9
Al-Ani A1, Al-Jalham K, Ibrahim T et al. Factors determining renal impairment in unilateral ureteral colic secondary to calcular disease: a prospective study. Int Urol Nephrol. 2015; 47(7):1085-1090
(check this in PDF content)
10
Bagshaw SM, Hoste EA, Braam B, Briguori C, Kellum JA, McCullough PA, Ronco C. Cardiorenal syndrome type 3: pathophysiologic and epidemiologic considerations. Contrib Nephrol 2013;182:137-157
(check this in PDF content)
11
Bainey KR, Rahim S, Etherington K et al. Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial. Am Heart J 2015;170(1):110-116
(check this in PDF content)
12
Basi S, Pupim LB, Simmons EM, et al. Insulin resistance in critically ill patients with acute renal failure. Am J Physiol Renal Physiol 2005; 289: F259–264
(check this in PDF content)
13
Bellomo R, Ronco C, Kellum JA et al. Acute Dialysis Quality Initiative workgroup. Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis
(check this in PDF content)
14
Quality Initiative (ADQI) Group. Crit Care 2004;8:R204–R212
(check this in PDF content)
15
Bellomo R, Cass A, Cole L et al. Intensity of continuous renal replacement therapy in critically ill patients. N Engl J Med 2009; 361: 1627-1638
(check this in PDF content)
16
Bonventre JV, Vaidya VS, Schmouder R et al. Next-generation biomarkers for detecting kidney toxicity. Nat Biotechnol 2010; 28 (5): 436–440
(check this in PDF content)
17
Bouman C , KellumJ A, Levin N. Definition of acute renal failure. Acute Dialysis Quality Initiative. 2nd International Consensus Conference, 2002; National Kidney Foundation KD: Clinical practice guidelines for chronic Kidney disease: Evaluation, classification and stratification. Am J Kidney Dis 2002;39 [Suppl 1]: S1-S266
(check this in PDF content)
18
Bucaloiu ID, Kirchner HL, Norfolk ER et al. Increased risk of death and de novo chronic kidney disease following reversible acute kidney injury. Kidney Int 2012; 81(5): 477–485
(check this in PDF content)
19
Case J, Khan S, Khalid R, Khan A. Epidemiology of acute kidney injury in the intensive care unit. Crit Care Res Pract 2013; 2013:479730. doi: 10.1155/2013/479730. Epub 2013 Mar 21
(check this in PDF content)
20
Casaer MP, Mesotten D, Schetz MR. Bench-to-bedside review: metabolism and nutrition. Crit Care 2008;12(4):222
(check this in PDF content)
21
Chowdhury AH, Cox EF, Francis ST, Lobo DN. A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and plasma-lyte(R) 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Annals of Surgery 2012; 256 (1): 18-24
(check this in PDF content)
22
Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta—analysis.
(check this in PDF content)
23
Kidney Int 2012; 81(5): 442–448
(check this in PDF content)
24
Cogliati AA, Vellutini R, Nardini A et al. Fenoldopam infusion for renal protection in high-risk cardiac surgery patients: a randomized clinical study. J Cardiothorac Vasc Anesth 2007; 21: 847-885
(check this in PDF content)
25
Conti M, Moutereau S, Zater M et al. Urinary cystatin C as a specifi c marker of tubular dysfunction. Clin Chem Lab Med 2006; 44(3): 288–291
(check this in PDF content)
26
Chertow GM, Burdick E, Honour M et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005; 16: 3365–3370
(check this in PDF content)
27
Edelstein C.L. Biomarkers in Kidney Disease. Elsevier Inc., 2011
(check this in PDF content)
28
Ertmer C., Rehberg S., Van Aken H et al. Relevance of non-albumin colloids in intensive care medicine. Best Pract Res Clin Anaesthesiol 2009; 23: 193–212
(check this in PDF content)
29
European Best Practice Guidelines for Haemodialysis (Part 1). V. Chronic intermittent haemodialysis and prevention of clotting in the extracorporal system. Nephrol Dial Transplant 2002; 17 (Suppl 7): 63-71
(check this in PDF content)
30
Fiaccadori E, Regolisti G, Cabassi A. Specific nutritional problems in acute kidney injury, treated with non-dialysis and dialytic modalities. NDT Plus. 2010;3(1):1-7
(check this in PDF content)
31
Fiaccadori E, Regolisti G, Maggiore U. Specialized nutritional support interventions in critically ill patients on renal replacement therapy. Curr Opin Clin Nutr Metab Care 2013;16(2):217-224
(check this in PDF content)
32
Fouque D, Kalantar-Zadeh K, Kopple J et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008;73(4):391-398
(check this in PDF content)
33
Friedrich JO, Adhikari N, Herridge MS, Beyene J. Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann Intern Med 2005; 142: 510-524
(check this in PDF content)
34
Fuiano G, Mazza G, Comi N et al. Current indications for renal biopsy: a questionnaire-based survey. Am J Kidney Dis 2000; 35(3): 448–457
(check this in PDF content)
35
Geus H, Betjes M, Bakker J. Biomarkers for the prediction of acute kidney injury: a narrative review on current status and future challenges. Clin Kidney J 2012; 5(2): 102–108
(check this in PDF content)
36
Giampietri C, Starace D, Petrungaro S et al. Necroptosis: Molecular signalling and translational Implications. Int J Cell Biol 2014; 2014:490275
(check this in PDF content)
37
Gibney NI, Hoste E, Burdmann EA et al. Timing of initiation and discontinuation of renal replacement therapy in AKI: unanswered key questions. Clin J Am Soc Nephrol 2008;3(3):876-880
(check this in PDF content)
38
Haase M, Bellomo R, Haase-Fielitz A. Serum cystatin C may diagnose rather than predict acute kidney injury. Am J Kidney Dis 2012; 59(4): 582
(check this in PDF content)
39
Haase N, Perner A, Hennings LI et al. Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis. BMJ 2013; 346: f839
(check this in PDF content)
40
Hirschberg RI, Kopple J, Lipsett P et al. Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure. Kidney Int 1999;55(6):2423-2432
(check this in PDF content)
41
Ho KM, Power BM. Benefits and risks of furosemide in acute kidney injury. Anaesthesia 2010; 65 (3): 283-293
(check this in PDF content)
42
Hoste EA, Clermont G, Kersten A et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care 2006;10(3): R73
(check this in PDF content)
43
Jones J, Holmen J, De Graauw J et al. Association of complete recovery from acute kidney injury with incident CKD stage 3 and all-cause mortality. Am J Kidney Dis 2012; 60(3):402-408
(check this in PDF content)
44
Hsu CY, McCulloch CE, Fan D et al. Community-based incidence of acute renal failure. Kidney Int 2007; 72: 208-212
(check this in PDF content)
45
Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute
(check this in PDF content)
46
Kidney Injury. Kidney Int Suppl 2012; Issue 1: 1–126
(check this in PDF content)
47
Korkeila M, Ruokonen E, Takala J. Costs of care, long-term prognosis and quality of life in patients requiring renal replacement therapy during intensive care. Intensive Care Med 2000;26:1824–1831
(check this in PDF content)
48
Lewington AJP, Cerdá J, Mehta RL. Raising awareness of Acute Kidney Injury: A global perspective of a silent killer. Kidney Int 2013; 84(3): 457–467
(check this in PDF content)
49
Liano F, Pascual J. Epidemiology of acute renal failure: a prospective, multicenter, community-basedstudy. Madrid Acute Renal
(check this in PDF content)
50
Failure Study Group. Kidney Int 1996; 50: 811-818
(check this in PDF content)
51
Lim W, Cook DJ, Crowther MA. Safety and efficacy of low molecular weight heparins for hemodialysis in patients with end-stage renal failure: a meta-analysis of randomized trials. J Am Soc Nephrol 2004; 15: 3192–3206
(check this in PDF content)
52
Lobo DN, Stanga Z, Aloysius MM et al. Effect of volume loading with 1 liter intravenous infusions of 0.9% saline, 4% succinylated gelatine (Gelofusine) and 6% hydroxyethyl starch (Voluven) on blood volume and endocrine responses: a randomized, three-way crossover study in healthy volunteers. Critical Care Medicine 2010; 38 (2): 464-470
(check this in PDF content)
53
Lopez-Gomez JM, Rivera F. Renal biopsy findings in acute renal failure in the cohort of patients in the Spanish Registry of Glomerulonephritis. Clin J Am SocNephrol 2008; 3(3): 674–681
(check this in PDF content)
54
Macedo E, Bouchard J, Soroko SH et al. Fluidh accumulation, recognition and staging of acute kidney injury in critically-ill patients.
(check this in PDF content)
55
Crit Care 2010;14(3): R82
(check this in PDF content)
56
Mammen C, Al Abbas A, Skippen P et al. Long—term risk of CKD in children surviving episodes of acute kidney injury in the intensive care unit: a prospective cohort study. Am J Kidney Dis 2012; 59(4): 523–530
(check this in PDF content)
57
Mårtensson J, Martling CR, Bell M. Novel biomarkers of acute kidney injury and failure: clinical applicability.Br J Anaesth 2012;109(6):843-850
(check this in PDF content)
58
Mehta RL, Kellum JA, Shah SV et al. Acute Kidney Injury Network. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007;11(2):R31
(check this in PDF content)
59
Murugan R, Kellum http://www.ncbi.nlm.nih.gov/pubmed?term=Kellum%20JA%5bAuthor%5d&cauthor=true&cauthor_ uid=21343898JA. Acute kidney injury: what’s the prognosis? Nat Rev Nephrol 2011; 7: 209 – 217
(check this in PDF content)
60
Noto A, Cibecchini F, Fanos V et al. NGAL and metabolomics: the single biomarker to reveal the metabolome alterations in kidney injury. Biomed Res Int 2013; id 612032
(check this in PDF content)
61
Palevsky PM, Zhang JH, O’Connor TZ et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008; 359: 7-20
(check this in PDF content)
62
Patel K, King CA, Jovin IS.Angiotensin-converting enzyme inhibitors and their effects on contrast-induced nephropathy aft er cardiac catheterization or percutaneous coronary intervention. Cardiovasc Revasc Med 2011; 12:. 90–93
(check this in PDF content)
63
Palevsky PM, Liu KD, Brophy PD et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury.
(check this in PDF content)
64
Am J Kidney Dis 2013; 61(5):649-672
(check this in PDF content)
65
Peng F, Su J, Lin J, Niu W. Impact of renin-angiotensin-aldosterone system-blocking agents on the risk of contrast-induced acute kidney injury: a prospective study and meta-analysis. J Cardiovasc Pharmacol 2015;65(3):262-268.
(check this in PDF content)
66
Piccinni P, Cruz DN, Gramaticopolo S et al. NEFROINT investigators. Prospective multicenter study on epidemiology of acute kidney injury in the ICU: a critical care nephrology Italian collaborative effort (NEFROINT). Minerva Anestesiol 2011;77:1072–1083
(check this in PDF content)
67
Rivera F, Lopez-Gomez JM, Perez-Garcia R. Clinicopathologic correlations of renal pathology in Spain. Kidney Int 2004; 66(3): 898–904
(check this in PDF content)
68
Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. J. Cardiorenal syndrome. Am Coll Cardiol 2008;52(19):1527-1539
(check this in PDF content)
69
Rosenzweig B, Pinthus JH, Kleinmann N et al. The relative contribution of urine extravasation to elevate plasma creatinine levels in acute unilateral ureteral obstruction. Can Urol Assoc J. 2015; 9(7-8):E428-433
(check this in PDF content)
70
Salvadori M, Bertoni E. Update on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations. World J Nephrol 2013; 2(3): 56–76.
(check this in PDF content)
71
Scheinkestel CD, Kar L, Marshall K et al. Prospective randomized trial to assess caloric and protein needs of critically ill, anuric, ventilated patients requiring continuous renal replacement therapy. Nutrition 2003;19(11-12):909-916
(check this in PDF content)
72
Shamir MY, Kaplan L, Marans RS et al. Urine fl ow is a novel hemodynamic monitoring tool for the detection of hypovolemia. Anesth Analg 2011; 112(3): 593–596
(check this in PDF content)
73
Slocum JL, Heung M, Pennathur S. Marking renal injury: can we move beyond serum creatinine? Transpl Res 2012;159(4):277-289
(check this in PDF content)
74
Sward K, Valsson F, Odencrants P et al. Recombinant human atrial natriuretic peptide in ischemic acute renal failure: a randomized placebocontrolled trial. Crit Care Med 2004; 32: 1310–1315
(check this in PDF content)
75
Tagawa M, Ogata A, Hamano T. Pre- and/or Intra-Operative Prescription of Diuretics, but Not Renin-Angiotensin-System Inhibitors, Is Significantly Associated with Acute Kidney Injury after Non-Cardiac Surgery: A Retrospective Cohort Study. PLoS One 2015 Jul 6;10(7):e0132507. doi: 10.1371
(check this in PDF content)
76
Tesch GH. Review: Serum and urine biomarkers of kidney disease: A pathophysiological perspective. Nephrology (Carlton) 2010; 15(6): 609–616.
(check this in PDF content)
77
Thakar CV, Christianson A, Almenoff P et al. Degree of acute kidney injury before dialysis initiation and hospital mortality in critically ill patients. Int J Nephrol 2013; 2013: 827459
(check this in PDF content)
78
Umruddin Z, Moe K, Superdock K. ACE inhibitor or angiotensin II receptor blocker useis a risk factor for contrast-induced nephropathy. J Nephrol 2012; 25(5): doi: 10.5301/jn.5000059.
(check this in PDF content)
79
Wiedermann CJ. Systematic review of randomized clinical trials on the use of hydroxyethyl starch for fluid management in sepsis.
(check this in PDF content)
80
BMC Emerg Med 2008; 8: 1-8
(check this in PDF content)
81
Wu VC, Wu CH, Huang TM et al. Long-Term risk of coronary events after AKI. J Am Soc Nephrol; doi: 10.1681/ASN.2013060610, 6 February 2014
(check this in PDF content)
82
Waikar SS, Liu KD, Chertow GM. Diagnosis, epidemiology and outcomes of acute kidney injury. Clin J Am Soc Nephrol 2008; 3(3):844-861
(check this in PDF content)
83
Waikar SS, Bonventre JV. Creatinine kinetics and the definition of acute kidney injury. J Am Soc Nephrol 2009; 20(3):672-679
(check this in PDF content)
84
Wu PC, Wu CJ, Lin CJ et al. Long-term risk of upper gastrointestinal hemorrhage after advanced AKI. Clin J Am Soc Nephrol 2015;10(3):353-362
(check this in PDF content)
85
Yang RL, Wang XT, Liu DW, Liu SB. Energy and oxygen metabolism disorder during septic acute kidney injury. Kidney Blood Press Res 2014;39(4):240-251
(check this in PDF content)
86
Zeng X, McMahon GM, http://www.ncbi.nlm.nih.gov/pubmed/?term=Brunelli%20SM%5BAuthor%5D&cauthor=true&cauth or_uid=24178971, Bates DW, Waikar SS. Incidence, outcomes, and comparisons across definitions of AKI in hospitalized individuals.
(check this in PDF content)
87
Clin J Am Soc Nephrol 2014; 9(1):12-20
(check this in PDF content)
88
Zhang Z, Lu B, Sheng X et al. Cystatin C in prediction of acute kidney injury: a systemic review and meta-analysis. Am J Kidney Dis 2011; 58(3): 356–365 Авторы заявляют об отсутствии конфликта интересов. Поступила в редакцию: 01.11.2015 г. Принята в печать: 07.12.2015 г.
(check this in PDF content)